1
Pegvisomant was able to ablate the effects of growth hormone on DCs.
2
Moreover, inhibition of NF-kappaB was able to block THC-induced apoptosis in DCs.
3
Therefore, the kinetics of regulatory DCs in T. evansi-infected mice were investigated.
4
IL-10 can affect the immune regulatory functions of DCs in various ways.
5
In cases of DCS-I, joint pain was easily relieved with controlled descent.
1
Conclusions and relevance: D-cycloserine is associated with a small augmentation effect on exposure-based therapy.
2
We suggest this occurs by ring opening of the cycloserine ring followed by decarboxylation.
3
Patients receiving 15 mg of cycloserine improved significantly on one section of an implicit memory test.
4
Beta-chloro-L-alanine and L-cycloserine were found to generate characteristic PLP-adducts that produced inactivation of SPT in an irreversible manner.
5
Cycloserine was well tolerated but did not demonstrate consistent evidence of efficacy during the course of therapy.
1
Pharmacological agents such as the NMDA receptor glycine site agonists d-cycloserine and d-serine can facilitate extinction and then attenuate the expression of drug reward memory.
2
D-Cycloserine participants gained 3 pounds relative to 0.5 pounds in the placebo group.
3
Participants completed psychoeducation and 4 sessions of exposure therapy, with medication (D-cycloserine vs placebo) given prior to the first 3 exposure sessions.